U.S. Physical Therapy (USPH) shareholders approved all three proposals at the annual meeting held May 19, 2026, as per an SEC filing.
USPH shares trade at $61.61, near the 52-week low of $58.19, down roughly 21% year-to-date. Bond.az analysis suggests the stock is undervalued, trading below Fair Value.
Seven directors were elected. Votes: Christopher J. Reading (13,850,539 for), Dr. Bernard A. Harris, Jr. (13,260,431), Kathleen A. Gilmartin (13,294,742), and others.
The advisory vote on executive compensation passed with 13,203,434 in favor. The ratification of Grant Thornton LLP as auditor received 14,475,354 votes for.
The company has raised dividends for five consecutive years, offering a current yield of 2.99%.












